Trials / Unknown
UnknownNCT04799327
The Effect of SHR20004（Noiiglutide ） on Body Weight in Obese Subjects Without Diabetes
A Multi-center, Randomized, Double-blind, Placebo-controlled，Parallel-group Clinical Trial to Assess the Efficacy and Safety of Noiiglutide Injection in Obese Subjects Without Diabetes.
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 254 (actual)
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The study is being conducted to assess the efficacy and safety of SHR20004 on body weight in obese subjects without diabetes.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | SHR20004 | SHR20004：low dose |
| DRUG | SHR20004 | SHR20004: medium dose |
| DRUG | SHR20004 | SHR20004: high dose |
| DRUG | placebo | Placebo |
Timeline
- Start date
- 2021-03-29
- Primary completion
- 2022-05-15
- Completion
- 2022-05-15
- First posted
- 2021-03-16
- Last updated
- 2022-03-15
Locations
2 sites across 1 country: China
Source: ClinicalTrials.gov record NCT04799327. Inclusion in this directory is not an endorsement.